You just read:

Dipexium Granted Special Protocol Assessment by the FDA for Phase 3 Registration Trial in Mildly Infected Diabetic Foot Ulcers With Locilex™

News provided by

Dipexium Pharmaceuticals

Jan 03, 2013, 08:00 EST